Get the Stockscreener App
1.54
1.28%
-0.02
After Hours:
1.55
0.01
+0.65%
Nyxoah Sa stock is traded at $1.54, with a volume of 177.80K.
It is down -1.28% in the last 24 hours and down -3.75% over the past month.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
See More
Previous Close:
$1.56
Open:
$1.58
24h Volume:
177.80K
Relative Volume:
0.61
Market Cap:
$154.11M
Revenue:
$17.85M
Net Income/Loss:
$-96.93M
P/E Ratio:
-0.6226
EPS:
-2.4735
Net Cash Flow:
$-88.29M
1W Performance:
-2.53%
1M Performance:
-3.75%
6M Performance:
-67.58%
1Y Performance:
-80.60%
1-Day Range:
$1.52
$1.58
1-Week Range:
$1.52
$1.67
52-Week Range:
$1.26
$8.5878
Nyxoah Sa Stock (NYXH) Company Profile
Name
Nyxoah Sa
Sector
Industry
Phone
-
Address
-
Compare NYXH vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
1.54 | 156.11M | 17.85M | -96.93M | -88.29M | -2.4735 |
ISRG
Intuitive Surgical Inc
|
350.06 | 125.08B | 11.03B | 3.16B | 2.83B | 8.7254 |
BDX
Becton Dickinson Co
|
153.84 | 42.57B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.09 | 32.88B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.35 | 34.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
195.80 | 28.81B | 5.54B | 1.52B | 1.74B | 10.37 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-21-22 | Initiated | Oppenheimer | Outperform |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Dec-21-21 | Resumed | Cantor Fitzgerald | Overweight |
| Jul-28-21 | Initiated | Cantor Fitzgerald | Overweight |
View All
Nyxoah Sa Stock (NYXH) Latest News
Nyxoah (NYXH) Q1 2025 earnings summary - Quartr
Nyxoah Shares Slide Over 4% as Stock Approaches Key Support LevelMFI Oversold - dars.gov.et
Nyxoah (NYXH) Q1 2026 Earnings: Smaller-Than-Expected Loss Surprises but Stock DeclinesEPS Growth Rate - dars.gov.et
Discipline and Rules-Based Execution in NYXH Response - Stock Traders Daily
Nyxoah touts Genio US launch traction, reimbursement stability at investor day - MSN
Price to sales forward of Nyxoah SA – SWB:5YI - TradingView
Nyxoah Touts Genio U.S. Launch Traction, Reimbursement Stability at Investor Day - Yahoo Finance
Nyxoah (NASDAQ: NYXH) posts Q2 2026 prelims, secures $110M and sees CMS propose higher Genio reimbursement - Stock Titan
Stifel reiterates Hold on Nyxoah stock, keeps $3 price target By Investing.com - Investing.com India
Price to earnings forward of Nyxoah SA – SWB:5YI - TradingView
Baird Maintains Nyxoah SA(NYXH.US) With Hold Rating, Cuts Target Price to $2.85 - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
Stifel reiterates Hold on Nyxoah stock, keeps $3 price target - Investing.com
Nyxoah reports Q2 2026 preliminary revenue of €7.7M - MSN
Stifel maintains Hold on Nyxoah stock, cites cash flow concerns By Investing.com - Investing.com Nigeria
Nyxoah preliminary net revenue up 21% to €7.7M in Q2 2026 - Medical Buyer
Stifel maintains Hold on Nyxoah stock, cites cash flow concerns - Investing.com
Nyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Capital Raise And Analyst Caution - Yahoo Finance
Nyxoah (NYXH) Reports Strong Momentum and Financial Progress in Q2 - GuruFocus
Nyxoah Rides U.S. Momentum and CMS Boost in Strong Q2 Preliminary Results - TipRanks
Revenue Expectations for NYXH Set Between EUR 36 Million and EUR 40 Million - GuruFocus
Nyxoah Backs FY26 Rev EUR36M-EUR40M >NYXH.BT - Moomoo
Nyxoah Preliminary Q2 Revenue Rises From Q1; 2026 Outlook Reaffirmed - Moomoo
Nyxoah sees Q2 revenue EUR 7.7M - TipRanks
Nyxoah Announces Preliminary Results for the Second Quarter of 2026 - The Manila Times
Nyxoah says U.S. launch lifted Q2 revenue 21% sequentially - Stock Titan
Nyxoah (NYXH) Dips 3.37% as Shares Test Key Support ZoneIceberg Order - dars.gov.et
NYXHNyxoah SA Latest SEC Filings - Finviz
Invitation to Attend the Extraordinary Shareholders' Meeting of the Company to Be Held on July 9, 2026 - 富途牛牛
ResMed (NYSE: RMD) reports 1.95% stake in Nyxoah — 1.94M shares - Stock Titan
Information on the total number of voting rights and shares - GlobeNewswire
Behavioral Patterns of NYXH and Institutional Flows - Stock Traders Daily
Price to book forward of Nyxoah SA – EURONEXT:NYXH - TradingView
Enterprise value to EBITDA forward of Nyxoah SA – EURONEXT:NYXH - TradingView
Nyxoah adds 146,531 shares as voting rights reach 100.1 million - Stock Titan
Enterprise value to revenue forward of Nyxoah SA – EURONEXT:NYXH - TradingView
Nyxoah sees Orin Hirchman cross 10% voting rights threshold, Resmed drops below 3%. - Pluang
Nyxoah gets two ownership notices: AIGH at 14.55%, Resmed at 1.95% - Stock Titan
Price to earnings forward of Nyxoah SA – LSX:A2QCWK - TradingView
Price to sales forward of Nyxoah SA – LSX:A2QCWK - TradingView
Nyxoah SA Actuals & Estimates (EURONEXT:NYXH) - TradingView
NYXH Forecast — Price Target — Prediction for 2027 - TradingView
Nyxoah to Host Investor Day in New York on July 8, 2026 - Sahm
Nyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Analyst Cuts And Capital Concerns - Yahoo Finance
Form 6K Nyxoah For: 23 June By Investing.com - Investing.com Nigeria
Nyxoah (NASDAQ: NYXH) adds $15M EIB debt and details major holders - Stock Titan
Nyxoah SA (NYXH) may report negative earnings: Know the trend ahead of next week's release - MSN
Nyxoah Sa Stock (NYXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.63%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):